Results 151 to 160 of about 35,220 (306)

Improving glycaemic outcomes with subsidised access to diabetes technology in a young adult population with type 1 diabetes

Diabetic Medicine, EarlyView.
Abstract Aims The availability of diabetes technologies has increased, although access can be limited for young people with type 1 diabetes (T1D). In Australia, access to subsidised continuous glucose monitors (CGM) has expanded significantly, while insulin pump access remains limited.
Andrew‐Hyun Lee, Gabrielle Stokes, Kaye Farrell, Deborah Jane Holmes‐Walker   +3 more
wiley   +1 more source

Continuous subcutaneous insulin infusion therapy: effects on quality of life

Swiss Medical Weekly, 2007
U Scheidegger, S Allemann
doaj   +1 more source

Early use of neutral Protamine Hagedorn (NPH) insulin in the management of diabetic ketoacidosis: an open-label randomized controlled trial in a resource-limited setting

BMC Research Notes
Objective Regular insulin infusion and intravenous fluids are the cornerstones of managing diabetic ketoacidosis (DKA). To shorten the time taken to resolve DKA in known diabetic patients, the concomitant administration of glargine with regular insulin ...
Naveen Baby, Mukta Wyawahare, Dukhabandhu Naik, Nishaant Ramasamy   +3 more
doaj   +1 more source

Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review. [PDF]

BMC Endocr Disord, 2022
Alvarenga CS, La Banca RO, Neris RR, de Cássia Sparapani V, Fuentealba-Torres M, Cartagena-Ramos D, Leal CL, Esper MV, Nascimento LC.   +8 more
europepmc   +1 more source

Sampling duration matters: Intraindividual variation of glycaemic metrics in type 1 diabetes using automated insulin delivery

Diabetic Medicine, EarlyView.
Abstract Introduction Understanding intraindividual variability in glycaemic metrics among users of automated insulin delivery (AID) is essential for interpreting data from continuous glucose monitoring (CGM). Methods CGM data over 56 days were collected from 142 individuals with type 1 diabetes using AID systems.
Bo Martin Bibby, Ermina Bach, Mia Christensen, Sanne Fisker, Klavs Würgler Hansen   +4 more
wiley   +1 more source

Effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections on glycaemic control among older adults with type 2 diabetes: protocol for systematic review and meta-analysis. [PDF]

BMJ Open, 2023
Yang B, Han L, Wang Y, Cheng K.
europepmc   +1 more source

Mind the gap: Ongoing inequalities in glycaemic levels in young people living with Type 1 diabetes across England and Wales

Diabetic Medicine, EarlyView.
Inequalities in glycaemic outcomes for young people living with Type 1 Diabetes in England and Wales. Abstract Aims Inequalities in glycaemic levels in children and young people (CYP) living with Type 1 diabetes (T1D) across different ethnic and socio‐economic groups in England and Wales were first highlighted in 2016.
Victoria Homer, Cillian Brophy, Robert French, Amani Krayem, Saira Pons Perez, Justin T. Warner, Renuka P. Dias   +6 more
wiley   +1 more source

Advancing continuous subcutaneous insulin infusion in vivo: New insights into tissue challenges. [PDF]

J Biomed Mater Res A, 2021
Kesserwan S, Mulka A, Sharafieh R, Qiao Y, Wu R, Kreutzer DL, Klueh U.   +6 more
europepmc   +1 more source

Continuous Subcutaneous Insulin Infusion [PDF]

Diabetes Care, 1993
openaire   +1 more source

Rethinking control‐IQ+ technology: Simple strategies for easy optimization

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Control‐IQ+ is an automated insulin delivery (AID) algorithm approved for people with type 1 diabetes aged 2+ years and adults aged 18+ years with type 2 diabetes. While numerous publications support improved glycaemia and quality of life for people with diabetes, this practice paper is intended to encourage uptake for healthcare professionals
Viral N. Shah, Pratik Choudhary, Ilana Halperin, Ivana Rabbone, Dessi P. Zaharieva, Laurel Messer   +5 more
wiley   +1 more source